This Medicine requires a physician's prescription.

Generic Name: Apixaban

Brand Name: Eliquis®

Strength: 2.5mg

Form: Film-Coated Tablets

Manufacturer: Catalent Anagni S.r.l. Loc Fontana del Ceraso SNC

Marketing Authorization Holder: Pfizer, Inc.

Classification: Anticoagulants, Antiplatelets & Fibrinolytics (Thrombolytics)

Indication/Uses: Prevention of VTE in Surgical Patients: Elective hip or knee replacement surgery: Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip or knee replacement surgery.

Prevention of Stroke and Systemic Embolism in Patients with AF: Nonvalvular atrial fibrillation: Apixaban (Eliquis) is indicated to reduce the risk of stroke, systemic embolism, and death in patients with nonvalvular atrial fibrillation with one or more risk factors, including patients unsuitable for warfarin. Compared to warfarin, Apixaban (Eliquis) also results in less bleeding, including intracranial hemorrhage.

Treatment of VTE: Apixaban (Eliquis) is indicated for: Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE); Prevention of recurrent DVT and PE.